WR-238605 Produkt Beschreibung

CAS-Nr.	106635-81-8
Bezeichnung:
Englisch Name:	WR-238605
Synonyma:	SB-252263;WR-238605;Wr238605 succinate;Tafenoquine Succinate;N-[2,6-Dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl]pentane-1,4-diamine;Butanedioic acid, compd. with N(sup 4)-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine (1:1)
CBNumber:	CB82360531
Summenformel:	C28H34F3N3O7
Molgewicht:	581.5806696
MOL-Datei:	106635-81-8.mol

WR-238605 physikalisch-chemischer Eigenschaften

storage temp. :

2-8°C

Sicherheit

WR-238605 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden
Tatenoquine is a new 8-aminoquinoline with an improved therapeutic index and safety profile as compared to primaquine (P733500).Tafenoquine has the potential to become a widely used drug in the preven tion and treatment of malaria infection and could replace some currently used drugs as resistant strains of Plasmodium species increase.

WR-238605 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

WR-238605 Anbieter Lieferant Produzent Hersteller Vertrieb Händler. Global( 5)Lieferanten

Firmenname	Telefon	Fax	E-Mail	Land	Produktkatalog	Edge Rate
J & K SCIENTIFIC LTD.	--	--	jkinfo@jkchemical.com;market3@jkchemical.com	CHINA	96847	76
Shanghai Aladdin Bio-Chem Technology Co.,LTD	021-20337333/400-620-6333	021-50323701	sale@aladdin-e.com	CHINA	24330	65

106635-81-8(WR-238605)Verwandte Suche:

WR-238605 106635-81-8 Butanedioic acid, compd. with N(sup 4)-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine (1:1) Wr238605 succinate Tafenoquine Succinate N-[2,6-Dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl]pentane-1,4-diamine SB-252263